North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Results
Looking for
Brolucizumab
found
4 matches
Open monograph to display formulary status
BNF Category
Brolucizumab
(Beovu
®
)
Eye - Subfoveal choroidal neovascularisation - 11.08.02
Links
Link to Drug Section
Link to document
MHRA Drug Safety Update (Jan 2022): Brolucizumab (Beovu▼): risk of intraocular inflammation and retinal vascular occlusion increased with short dosing intervals (11.08.02)
NICE TA672: Brolucizumab for treating wet age-related macular degeneration (11.08.02)
NICE TA820: Brolucizumab for treating diabetic macular oedema (11.08.02)
